These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 3861611)
21. HLA class II DNA genotypes in Graves' disease: clues to inheritance of the HLA-linked component of susceptibility. Fletcher J; Franklyn JA; McLachlan SM; Young E; Sheppard MC Clin Endocrinol (Oxf); 1988 Nov; 29(5):539-47. PubMed ID: 2908104 [TBL] [Abstract][Full Text] [Related]
22. HLA and rheumatoid arthritis: an analysis of multicase families. Ollier W; Silman A; Gosnell N; Currey H; Awad J; Doyle P; McCloskey D; Alonso A; Hossain MA; Festenstein H Dis Markers; 1986 Jun; 4(1-2):85-98. PubMed ID: 3330700 [TBL] [Abstract][Full Text] [Related]
23. Immunogenetics of Hashimoto's and Graves' diseases. Tamai H; Uno H; Hirota Y; Matsubayashi S; Kuma K; Matsumoto H; Kumagai LF; Sasazuki T; Nagataki S J Clin Endocrinol Metab; 1985 Jan; 60(1):62-6. PubMed ID: 3838076 [TBL] [Abstract][Full Text] [Related]
24. HLA haplotypes and susceptibility to Graves' disease. De Rosa G; Testa A; Mariani M; Purpura M; Giacomini D Horm Res; 1992; 37(4-5):176-9. PubMed ID: 1490660 [TBL] [Abstract][Full Text] [Related]
25. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives. Mather BA; Roberts DF; Scanlon MF; Mukhtar ED; Davies TF; Smith BR; Hall R Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172 [TBL] [Abstract][Full Text] [Related]
26. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations. Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302 [TBL] [Abstract][Full Text] [Related]
27. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population. Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435 [TBL] [Abstract][Full Text] [Related]
28. Association of HLA-DR tissue types with Graves' disease in Taiwan. Tsai KS; Hsieh RP; Chang CC; Chen FW; Lee SC Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):336-41. PubMed ID: 2794934 [TBL] [Abstract][Full Text] [Related]
29. A study of human leukocyte D locus related antigens in Graves' disease. Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012 [TBL] [Abstract][Full Text] [Related]
30. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course. Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233 [TBL] [Abstract][Full Text] [Related]
31. HLA antigens and susceptibility to myasthenia gravis. Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039 [TBL] [Abstract][Full Text] [Related]
32. Population and family studies of HLA in Japanese with cleft lip and cleft palate. Watanabe T; Ohishi M; Tashiro H Cleft Palate J; 1984 Oct; 21(4):293-300. PubMed ID: 6595085 [TBL] [Abstract][Full Text] [Related]
33. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. Chen QY; Huang W; She JX; Baxter F; Volpe R; Maclaren NK J Clin Endocrinol Metab; 1999 Sep; 84(9):3182-6. PubMed ID: 10487684 [TBL] [Abstract][Full Text] [Related]
34. The genetics of Type 1 (insulin-dependent) diabetes. Cudworth AG; Wolf E Curr Probl Clin Biochem; 1983; 12():45-64. PubMed ID: 6418443 [TBL] [Abstract][Full Text] [Related]
35. MHC related genetic susceptibility to Hodgkin's disease. Kalidi I; Masset M; Gony J; Marcelli A; Jeannet M; Irlé C; Bauters F; Tchernia G; Turpin F; Gisselbrecht C Nouv Rev Fr Hematol (1978); 1989; 31(2):149-52. PubMed ID: 2771630 [TBL] [Abstract][Full Text] [Related]
36. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus. Skanes V; Larsen B; Sampson-Murphy L; Farid NR Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086 [TBL] [Abstract][Full Text] [Related]
38. The genetic susceptibility to insulin-dependent diabetes mellitus: combined segregation and linkage analysis. Green A; Svejgaard A; Platz P; Ryder LP; Jakobsen BK; Morton NE; MacLean CJ Genet Epidemiol; 1985; 2(1):1-15. PubMed ID: 3863777 [TBL] [Abstract][Full Text] [Related]
39. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. Singh SP; Mehra NK; Dingley HB; Pande JN; Vaidya MC J Infect Dis; 1983 Oct; 148(4):676-81. PubMed ID: 6415179 [TBL] [Abstract][Full Text] [Related]
40. HLA antigens in patients with and without a family history of schizophrenia. Rudduck C; Franzén G; Löw B; Rorsman B Hum Hered; 1984; 34(5):291-6. PubMed ID: 6592138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]